GenMont Biotech Incorporation (TPE:3164)

Taiwan · Delayed Price · Currency is TWD

17.95

-0.05 (-0.28%)

Mar 4, 2026, 1:35 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Genmont (China)	40.21M	8.57M	-	-	-
Genmont (China) Growth	369.18%	-	-	-	-
Genmont Biotech Inc.	345.16M	309.45M	368.55M	427.93M	325.19M
Genmont Biotech Inc. Growth	11.54%	-16.04%	-13.88%	31.59%	-6.08%
Total	385.37M	318.02M	368.55M	427.93M	325.19M
Total Growth	21.18%	-13.71%	-13.88%	31.59%	-6.08%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	191.42M	193.43M	211.27M	188.61M	185.85M
Taiwan Growth	-1.04%	-8.44%	12.01%	1.49%	0.99%
Singapore	69.60M	37.84M	-	-	-
Singapore Growth	83.94%	-	-	-	-
China	-	-	-	197.55M	113.82M
China Growth	-	-	-	73.56%	-22.09%
Other	45.93M	29.89M	44.70M	41.77M	25.52M
Other Growth	53.69%	-33.14%	7.03%	63.65%	58.18%
Mainland China	78.43M	56.86M	112.57M	-	-
Mainland China Growth	37.92%	-49.49%	-	-	-
Total	385.37M	318.02M	368.55M	427.93M	325.19M
Total Growth	21.18%	-13.71%	-13.88%	31.59%	-6.08%

Source: S&P Global Market Intelligence.